The University of Utah - Huntsman Cancer Institute (HCI) — Salt Lake City, Utah

The University of Utah - Huntsman Cancer Institute (HCI) is a clinical research site located in Salt Lake City, Utah, United States 84112.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Utah - Huntsman Cancer Institute (HCI) has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma, Advanced or Metastatic NRAS-mutant Melanoma.

Sponsors: Ono Pharmaceutical Co. Ltd, Erasca, Inc., Arcus Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Utah - Huntsman Cancer Institute (HCI)?

The University of Utah - Huntsman Cancer Institute (HCI) has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Utah - Huntsman Cancer Institute (HCI) conducted?

The University of Utah - Huntsman Cancer Institute (HCI) has 3 clinical trials on record, with 3 currently active. Their work covers Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma, Advanced or Metastatic NRAS-mutant Melanoma.

Is The University of Utah - Huntsman Cancer Institute (HCI) accredited by Crixeo Health?

The University of Utah - Huntsman Cancer Institute (HCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Utah - Huntsman Cancer Institute (HCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.